148 related articles for article (PubMed ID: 28700421)
21. Colon Metastasis From Microscopic Serous Carcinoma of the Fallopian Tube Fimbria Mimicking a Primary Colon Cancer.
Usui G; Masuda Y; Hashimoto H; Kusakabe M; Nakajima K; Tsunoda H; Matsuhashi N; Harihara Y; Horiuchi H; Morikawa T
Int J Surg Pathol; 2019 Jun; 27(4):390-395. PubMed ID: 30663467
[TBL] [Abstract][Full Text] [Related]
22. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.
Vang R; Shih IeM; Kurman RJ
Histopathology; 2013 Jan; 62(1):44-58. PubMed ID: 23240669
[TBL] [Abstract][Full Text] [Related]
23. Serous Tubal Intraepithelial Carcinoma (STIC)-like Lesions Arising in Ovarian Serous Cystadenofibroma: Report of 2 Cases.
Craig E; Clarke R; Rushton G; McCluggage WG
Int J Gynecol Pathol; 2015 Nov; 34(6):535-40. PubMed ID: 26107558
[TBL] [Abstract][Full Text] [Related]
24. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
25. Intrauterine device found in an ovarian tumor: A case report.
An Y; Liu C; Mao F; Yang G; Mao G
Medicine (Baltimore); 2020 Oct; 99(42):e22825. PubMed ID: 33080762
[TBL] [Abstract][Full Text] [Related]
26. Ovarian remnant syndrome with paraintestinal ovarian serous cystadenofibroma arose 30 years after bilateral salpingo-oophorectomy: A case report.
Tien CT; Cheng CH; Ding DC
Medicine (Baltimore); 2022 Nov; 101(44):e31205. PubMed ID: 36343074
[TBL] [Abstract][Full Text] [Related]
27. Pattern of HER-2 Gene Amplification and Protein Expression in Benign, Borderline, and Malignant Ovarian Serous and Mucinous Neoplasms.
Mohammed RAA; Makboul R; Elsers DAH; Elsaba TMAM; Thalab AMAB; Shaaban OM
Int J Gynecol Pathol; 2017 Jan; 36(1):50-57. PubMed ID: 27309616
[TBL] [Abstract][Full Text] [Related]
28. Ovarian neuroendocrine carcinoma, non-small cell type, associated with serous carcinoma.
Choi YD; Lee JS; Choi C; Park CS; Nam JH
Gynecol Oncol; 2007 Mar; 104(3):747-52. PubMed ID: 17229461
[TBL] [Abstract][Full Text] [Related]
29. The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report.
Mori R; Futamura M; Morimitsu K; Saigo C; Miyazaki T; Yoshida K
World J Surg Oncol; 2017 Jun; 15(1):117. PubMed ID: 28662703
[TBL] [Abstract][Full Text] [Related]
30. Primary endometrioid carcinoma of the uterosacral ligament arising from deep infiltrating endometriosis 6 years after bilateral salpingo-oophorectomy due to atypical proliferative endometrioid tumor of the ovary: a rare case report.
Ota Y; Ota K; Takahashi T; Suzki S; Sano R; Ota I; Moriya T; Shiota M
World J Surg Oncol; 2020 Dec; 18(1):329. PubMed ID: 33308243
[TBL] [Abstract][Full Text] [Related]
31. A diagnostic dilemma following risk-reducing surgery for BRCA1 mutation - a case report of primary papillary serous carcinoma presenting as sigmoid cancer.
Chand M; Moore PJ; Clarke AD; Nash GF; Hickisk T
World J Surg Oncol; 2007 Sep; 5():102. PubMed ID: 17850658
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic challenges on breast needle core biopsies. Case 7: Metastasis of ovarian cancer to the breast].
Michenet P
Ann Pathol; 2017 Oct; 37(5):402-407. PubMed ID: 28939203
[No Abstract] [Full Text] [Related]
33. Pitfalls of Frozen Section in Gynecological Pathology: A Case of Ovarian Serous Surface Papillary Adenofibroma Imitating Malignancy.
Jones AMK; Yue WY; Marcus J; Heller DS
Int J Surg Pathol; 2019 May; 27(3):268-270. PubMed ID: 30563377
[TBL] [Abstract][Full Text] [Related]
34. Metastatic ovarian serous carcinoma presenting as inflammatory breast cancer: a case report.
Gingell D; Samuel A; Haynik D; McBee W; Kelley J; Zorn K; Bhargava R
Int J Gynecol Pathol; 2010 May; 29(3):243-7. PubMed ID: 20407323
[TBL] [Abstract][Full Text] [Related]
35. Metastatic serous carcinoma presenting as inflammatory carcinoma over the breast-Report of two cases and literature review.
Panse G; Bossuyt V; Ko CJ
J Cutan Pathol; 2018 Mar; 45(3):234-239. PubMed ID: 29194708
[TBL] [Abstract][Full Text] [Related]
36. Concurrent primary peritoneal low-grade serous carcinoma and endometrial high-grade serous carcinoma.
Lockyer MG; Deavers MT; Zarrin-Khameh N
Int J Gynecol Pathol; 2015 May; 34(3):288-92. PubMed ID: 25760900
[TBL] [Abstract][Full Text] [Related]
37. Ovarian serous borderline tumors with noninvasive and invasive peritoneal implants: A case report each.
Srinivasamurthy BC; Kulandai Velu AR; Krishnan N; Patil AS
J Cancer Res Ther; 2015; 11(3):646. PubMed ID: 26458602
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic features of ovarian neoplasms with emphasis on borderline ovarian tumors: an institutional perspective.
Hashmi AA; Hussain ZF; Bhagwani AR; Edhi MM; Faridi N; Hussain SD; Khan M
BMC Res Notes; 2016 Apr; 9():205. PubMed ID: 27052022
[TBL] [Abstract][Full Text] [Related]
39. [Atypical debut of symptoms of fallopian tube cancer].
Hviid MM; Teklay B; Jensen PT
Ugeskr Laeger; 2013 Sep; 175(37):2114-5. PubMed ID: 24011209
[TBL] [Abstract][Full Text] [Related]
40. EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma.
Chen X; Wang X; Wei X; Wang J
J Ovarian Res; 2016 Nov; 9(1):83. PubMed ID: 27887627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
